The quest for the perfect biomarker of long-term glycemia: New studies, new trials and tribulations

Metabolism: Clinical and Experimental

Volumn 60, Issue 12, 2011, Pages 1651-1654

  Foo, Joo Pin ^a   Mantzoros, Christos S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; FRUCTOSAMINE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

CONFORMATIONAL TRANSITION; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBINOPATHY; HUMAN; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW;

EID: 81155133948     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.06.016     Document Type: Editorial

References (36)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med 329 1993 977
2. R.R. Holman, S.K. Paul, and M.A. Bethel 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577
3. International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 2009 1327
4. E. Bonora, S. Kiechl, A. Mayr, G. Zoppini, G. Targher, and R.C. Bonadonna High-normal HbA1c is a strong predictor of type 2 diabetes in the general population Diabetes Care 34 2011 1038 1040 [Epub 2011 Feb 9]
5. M.A. Abdul-Ghani, T. Abdul-Ghani, G. Müller, A. Bergmann, S. Fischer, and S. Bornstein Role of glycated hemoglobin in the prediction of future risk of T2DM J Clin Endocrinol Metab 2011 10.1210/jc.2010-1698 [Epub ahead of print]
6. Standards of medical care in diabetes-2011 Diabetes Care 34 2011 S11 S61 10.2337/dc11-S011
7. H. Dheir, M. Ozkahya, F. Kircelli, M. Sezis Demirci, G. Asci, and H. Toz Glycosylated hemoglobin levels are associated with cardiovascular events in nondiabetic peritoneal dialysis patients J Nephrol 2011 10.5301/JN.2011.8350 pii: 23CF5B25-8CF6-45DF-A5CA-C43FAF233D17. [Epub ahead of print]
8. ADVANCE Collaborative Group A. Patel, and S. MacMahon Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560
9. F. Ismail-Beigi, T. Craven, and M.A. Banerji Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Lancet 376 2010 419
10. W. Duckworth, C. Abraira, and T. Moritz Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129
11. D.C. Ziemer, P. Kolm, W.S. Weintraub, V. Vaccarino, M.K. Rhee, and J.G. Twombly Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies Ann Intern Med 152 2010 770 777
12. S. Panzer, G. Kronik, and K. Lechner Glycosylated hemoglobins (GHb): an index of red cell survival Blood 59 1982 1348
13. J.N. Brown, D.W. Kemp, and K.R. Brice Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis Pharmacotherapy 29 2009 468
14. W.L. Roberts, S. Safar-Pour, and B.K. De Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods Clin Chem 51 2005 776
15. D.A. Armbruster Fructosamine: structure, analysis, and clinical usefulness Clin Chem 33 1987 2153
16. J.R. Baker, P.A. Metcalf, I.M. Holdaway, and R.N. Johnson Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus Br Med J (Clin Res Ed) 290 1985 352
17. Y. Tahara, and K. Shima Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level Diabetes Care 18 1995 440 447
18. T.P. Peacock, Z.K. Shihabi, and A.J. Bleyer Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis Kidney Int 73 2008 1062
19. S. Yamada, M. Inaba, S. Okada, Y. Imanishi, K. Mori, and M. Emoto Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus Metabolism 59 2010 390 394 [Epub 2009 Oct 2]
20. C. Constanti, J.M. Simo, J. Joven, and J. Camps Serum fructosamine concentration in patients with nephrotic syndrome and with cirrhosis of the liver: the influence of hypoalbuminaemia and hypergammaglobulinaemia Ann Clin Biochem 29 1992 437 442
21. T. Okada, T. Nakao, H. Matsumoto, Y. Nagaoka, R. Tomaru, and H. Iwasawa Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease Intern Med 50 2011 23 29 [Epub 2011 Jan 1]
22. Lautenslager GT, Shearman CW, Hud E, Cohen MP. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin. Metabolism. 2011 May 30. [Epub ahead of print].
23. M.P. Cohen, F.N. Ziyadeh, and S. Chen Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications J Lab Clin Med 147 2006 211 219 (Pubitemid 43668486)
24. C. Stettler, M. Stahl, and S. Allemann Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients Diabetes Care 31 2008 1534 1535 PMCID: PMC2494656
25. M. Muggeo, G. Zoppini, E. Bonora, E. Brun, R.C. Bonadonna, and P. Moghetti Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study Diabetes Care 23 2000 45 50 (Pubitemid 30022893)
26. T.S. Temelkova-Kurktschiev, C. Koehler, E. Henkel, W. Leonhardt, K. Fuecker, and M. Hanefeld Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level Diabetes Care 23 2000 1830 1834
27. T.P. Erlinger, and F.L. Brancati Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes Diabetes Care 24 2001 1734 1738 (Pubitemid 33716474)
28. K.M. Dungan, J.B. Buse, and J. Largay 1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes Diabetes Care 29 2006 1214
29. M. Emoto, T. Tabata, T. Inoue, Y. Nishizawa, and H. Morii Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus Nephron 61 1992 181 186
30. E. Selvin, L.M. Francis, C.M. Ballantyne, R.C. Hoogeveen, J. Coresh, and F.L. Brancati Nontraditional markers of glycemia: associations with microvascular conditions Diabetes Care 34 2011 960 967 [Epub 2011 Feb 18]
31. M.P. Cohen, E. Hud, E. Shea, and C.W. Shearman Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice Metabolism 51 2002 901 905 (Pubitemid 34784819)
32. W.S. Browner, A.R. Pressman, L.Y. Lui, and S.R. Cummings Association between serum fructosamine and mortality in elderly women. The Study of Osteoporotic Fractures Am J Epidemiol 149 1999 471 475 (Pubitemid 29100785)
33. L. Lu, L.J. Pu, X.W. Xu, Q. Zhang, R.Y. Zhang, and J.S. Zhang Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus Clin Biochem 40 2007 810 816 (Pubitemid 46961968)
34. L.J. Pu, L. Lu, W.F. Shen, Q. Zhang, R.Y. Zhang, and J.S. Zhang Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients Circ J 71 2007 1067 1073 (Pubitemid 46998021)
35. B.I. Freedman, L. Andries, Z.K. Shihabi, M.V. Rocco, J.R. Byers, and C.Y. Cardona Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients Clin J Am Soc Nephrol 6 2011 1635 1643
36. R. Beck, M. Steffes, D. Xing, K. Ruedy, N. Mauras, and D.M. Wilson The Diabetes Res earch in Children Network (DirecNet) Study Group. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring Pediatr Diabetes 2011 10.1111/j.1399-5448.2011.00764.x [Epub ahead of print]